THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found. The trial, of nearly 700 people with treatment-resistant depression, found that esketamine nasal spray was moreContinue Reading

WEDNESDAY, Oct. 4, 2023 (HealthDay News) — New research has discovered 12 gene variants that may be tied to an increased risk of attempting suicide. These genes also may have links with physical and mental health woes, including chronic pain, attention-deficit/hyperactivity disorder (ADHD), lung conditions and heart disease. The researchersContinue Reading

TUESDAY, Oct. 3, 2023 (HealthDay News) — Some common medications — including antidepressants, sleep aids and painkillers — may dull the driving skills of seniors, a new study finds. Many different medication classes have been linked to the risk of driving impairment, as anyone who has ever read the labelContinue Reading